Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2

Source:https://financewire.com/2026/08/17/quantum-biopharma-nasdaq-qntm-cse-qntm-reports-lower-q2-expenses-advances-lucid-ms-into-phase-2/